Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F88QE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,941
Award facts
- Contract value 100% obligated
- $19,941.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 28, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $19,941.37 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award under the broader pharmaceutical supply framework supporting federal healthcare operations. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 29, 2026. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military treatment facilities and other federal medical institutions worldwide. Repatha, a PCSK9 inhibitor indicated for managing high cholesterol, represents the type of specialty pharmaceutical product routinely procured through this contract vehicle to support Defense Health Agency and related federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F88QE?
SPE2DR26F88QE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F88QE worth?
The government has obligated $19,941 on SPE2DR26F88QE.
Is contract SPE2DR26F88QE an order under another contract?
Yes. SPE2DR26F88QE is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88QE competed?
The extent of competition for SPE2DR26F88QE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award